JPMorgan's Principal Investment Management Group to Invest in Chindex Internati...( $50 Million Investment to Finance Gro...)

$50 Million Investment to Finance Growth in Chindex's Healthcare Network in

China

BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare services and products in the People's Republic of China, today announced that it has agreed to an investment by JPMorgan's Principal Investment Management group. The investment will consist of $10 million of the Company's common stock and $40 million of zero coupon convertible notes for aggregate proceeds of $50 million. The purchase price for the common stock and the conversion price of the notes will be $27.84 per share. The net proceeds from the investment will be used primarily toward the development of new hospitals in P.R. China. The closing of the investment is subject to certain conditions, including compliance with Nasdaq listing requirements.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing and Shanghai metropolitan areas. The Company sells medical products manufactured by various major multinational companies, including Siemens AG, which is the Company's exclusive distribution partner for the sale and servicing of color doppler ultrasound systems. It also arranges financing packages for the supply of medic
'/>"/>